- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Keynote: Future Thinking in Diabetes Care: The Impact of New Practice Models Robert Gabbay
Robert Gabbay, MD, PhD, discusses the changes he wishes to see in the healthcare system that he calls a "journey toward quality," and with his work at the Joslin Diabetes Center, he dreams of ridding the world of diabetes by implementing innovation.
Robert Gabbay, MD, PhD, discusses the changes he wishes to see in the healthcare system that he calls a “journey toward quality,” and with his work at the Joslin Diabetes Center, he dreams of ridding the world of diabetes by implementing innovation.
He claims that one of the keys to managing long-term diabetes—or any chronic disease—is to shift population management from treating 1 patient at a time to treating an entire population of patients concurrently at a practice. This can all be done, Dr Gabbay says, through a diabetes registry. “Measuring quality is really the first step to improving it,” he adds.
Dr Gabbay has found that team-based care, such as a collaboration between a physician, a dietician, and a diabetes educator, has led to improvement in patients’ overall health compared with the self-managed care model. The idea of incorporating a number of people to help in the process of treatment at every checkpoint as well as at various other steps along the way can also be applied to the treatment of many other chronic diseases.
In addition to improvement in patient care through patient outreach, interventions, and various tests, Dr Gabbay believes payment reform has an opportunity to push improvement and innovation in diabetes care in the right direction.
He says, “Most patients don’t just have diabetes. They have diabetes and its complications, but they also have other things, and so I think the key is using these same kinds of principles around the broader challenges that a patient brings.”
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
